drugset / Trial / NCT02536586

A Study of LY3023414 in Japanese Participants With Advanced Cancer

NCT02536586

Phase 1 Completed 12 enrolled Eli Lilly and Company
NaSingle-groupOpen-labelTreatment

Summary

The main purpose of this study is to evaluate the tolerability of an investigational drug known as LY3023414 in Japanese participants with advanced cancer or cancer that has spread to another part(s) of the body. The study will also explore the safety of the drug. It will measure how much of the drug gets into the blood steam and how long the body takes to get rid of it. It will investigate anti-cancer activity.

Timeline

Start
2015-09
Primary completion
2017-02-09
Completion
2017-02-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Samotolisib Small molecule Oral

Indications